The MyoStrand CR-400 is a modular synthetic muscle replacement system consisting of braided carbon-polymer actuation fibers embedded with piezoelectric contractile elements, designed to be surgically implanted alongside or in replacement of native muscle tissue. Each CR-400 bundle replicates the form factor of a standard human muscle fascicle and interfaces with existing motor nerve terminals via Helix's NeuroClamp junction collars, which are included in every installation kit. The system delivers approximately 4.2 times the contractile force of equivalent biological muscle mass while consuming roughly 60% of the metabolic energy, drawing supplemental power from a subcutaneous CascadeCell-compatible capacitor node. The CR-400 is notable for its tiered activation architecture — the fibers are organized into slow-twitch analog layers for sustained load-bearing and fast-twitch burst layers for explosive force output, with the ratio dynamically managed by an embedded microcontroller that reads nerve signal cadence. Unlike full-limb cybernetic replacement, MyoStrand installations preserve native skeletal and dermal structures, making them visually undetectable and avoiding the legal reclassification complications that come with registered prosthetic limbs under GLMZ's Augmentation Registry Act. Arcturus Defense Solutions licenses a hardened military variant for special operations units, while the civilian version flows through Helix's authorized surgical network and a substantial black-market channel.